TCM
CLOV icon

Tuttle Capital Management’s Clover Health Investments CLOV Stock Holding History

Tuttle Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-31,611
Closed -$118K – 103
2021
Q4 		$118K Buy
31,611
+20,653
+188% +$127K 0.18% 96
2021
Q3 		$81K Buy
10,958
+877
+9% +$7.5K 0.09% 109
2021
Q2 		$134K Buy
+10,081
New +$99K 0.06% 254

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tuttle Capital Management's CLOV Position: Q1 2022 in Review

Tuttle Capital Management sold out of Clover Health Investments (CLOV) in Q1 2022, closing a stake of 31,611 shares — an estimated $118K sold.

Tuttle Capital Management first reported a position in CLOV in Q2 2021 and held it in 3 quarters. The position peaked at $134K in Q2 2021. 168 funds tracked by Wall St. Rank hold CLOV as of Q1 2022.

  • Tuttle Capital Management reported no remaining Clover Health Investments position as of Q1 2022 after selling out during the quarter.
  • Tuttle Capital Management sold 31,611 Clover Health Investments shares in Q1 2022, an estimated $118K.
  • Tuttle Capital Management first reported a position in Clover Health Investments in Q2 2021 and held it in 3 quarters.
  • Tuttle Capital Management's Clover Health Investments position peaked at $134K in Q2 2021.
  • 168 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2022.

Based on Tuttle Capital Management's 13F filing for Q1 2022, filed 4 May 2022.